What makes them interesting scientifically?
Scientists have explored how MUSE-enriched cell populations behave in laboratory models of injury and stress. Experimental findings about homing, differentiation or signaling remain separate from human efficacy claims.
What is being investigated?
Researchers have explored possible applications in tissue injury and neurologic disease. There is insufficient evidence to establish that MUSE-cell infusion treats central sensitization, neuropathy, osteoarthritis or other chronic pain conditions.
Important uncertainties
Products may differ in how cells are isolated, counted, characterized and released. Optimal dose, administration route, long-term safety and meaningful clinical benefit for pain remain unestablished.
FDA and research oversight
No MUSE-cell product is FDA-approved for treating chronic pain. Any proposed human administration requires an appropriate, independently verified regulatory and research pathway; an observational registry alone does not provide authorization.